Stay updated with the latest generic-drug news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on generic-drug topics.
India's economic growth is projected to remain steady in the latter half of the fiscal year, driven by robust domestic consumption and increased government capital expenditure. Despite global trade uncertainties and US tariffs, internal demand provides stability, with festive sales expected to reach a record high. The RBI's measures to ease credit flow further support economic resilience. India's economic growth in the second half of the current financial year is expected to remain steady, with ...Read More >
Hyderabad: Laurus Labs on Thursday said it saw an 875% jump in consolidated net profit for the second quarter ended Sept 30, 2025, at ₹195 crore from ₹20 crore in the same quarter of the last financial year. The company's revenues climbed 35% year-on-year to ₹1,653 crore compared to ₹1,224 crore in Q2FY25.The company attributed the surge in profits and revenues to its expanding contract development and manufacturing organisation (CDMO) business and strong performance in generics, underpinned by ...Read More >
MUMBAI, India and NAPLES, Fla., Oct. 9, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of a strategic partnership program aimed at expanding the reach of PrecisionSphere™ - the long-acting injectable (LAI) platform developed by its subsidiary, Nanomi B.V. (Nanomi). PrecisionSphere™ demonstrates efficacy and safety in drug delivery and is ready for commercial use, following the recent Unit ...Read More >
Mumbai: Less than a month after Ozempic maker Novo Nordisk announced it is cutting its global workforce as part of a restructuring plan, the layoffs have hit Indian employees in Bengaluru. Junior- to mid-level employees across functions such as sales and marketing, as well as those in the company's global business services (GBS) hub, which works with its global teams, have been impacted, according to at least three people aware of the development. "At least 100-150 will be retrenched from the ...Read More >
New Delhi, Oct 1 (PTI) Drug maker Lupin on Wednesday said it has launched an anticoagulant medication in the US. The company has launched Rivaroxaban for Oral Suspension (1 mg/mL), a generic version of Janssen Pharmaceuticals, Inc.'s Xarelto for Oral Suspension, in the US, the drug maker said in a statement. Rivaroxaban for Oral Suspension is indicated for the treatment of venous thromboembolism (VTE) and the reduction in the risk of recurrent VTE in pediatric patients. It is also indicated f ...Read More >
New Delhi, Sep 30 (PTI) Pharmaceutical company Virupaksha Organics has filed preliminary papers with capital markets regulator Sebi to raise Rs 740 crore through an initial public offering (IPO). The proposed IPO of the Hyderabad-based company is entirely a fresh issue of equity shares, according to the draft red herring prospectus (DRHP) filed on Monday. The company may consider raising Rs 148 crore in a pre-IPO placement round. If such placement is undertaken, then the issue size will be red ...Read More >
Ahmedabad (Gujarat) [India], September 29: As India observes World Heart Day, the conversation around cardiovascular health has once again turned to prevention, timely treatment, and most importantly, access to affordable medicines for everyone. Heart disease remains the leading cause of death in India at 28.1%, with more than half a billion people affected by a heart ailment. While treatment protocols have advanced, the cost of long-term medication continues to be a burden for many families. Mo ...Read More >
NewsVoir Ahmedabad (Gujarat) [India], September 29: As India observes World Heart Day, the conversation around cardiovascular health has once again turned to prevention, timely treatment, and most importantly, access to affordable medicines for everyone. Heart disease remains the leading cause of death in India at 28.1%, with more than half a billion people affected by a heart ailment. While treatment protocols have advanced, the cost of long-term medication continues to be a burden for many fa ...Read More >
Mumbai, Sep 29 (SocialNews.XYZ) Shiv Sena(UBT) on Monday claimed that US President Trump has dealt a blow to Indian pharmaceutical companies by imposing a 100 per cent tariff on medicines, saying that it will devastate the Indian pharmaceutical industry and affect healthcare for the poor and middle class. "Trump, who is acting as if he is taking revenge on Indian business and industry, wants to destroy India's economy. He certainly wants to dent Prime Minister Narendra Modi's stated ambition to ...Read More >
For the month, FII sold equities worth Rs 30,141.68 crore, while DII bought equities worth Rs 55,736.09 crore. The broader indices broke a three-week gaining streak and underperformed the main indices as markets remained under pressure throughout the week on worries over fresh tariffs on pharma, higher visa fees by the US, persistent trade concerns, and continued FII selling. For the week, Nifty50 plunged 672.35 points or 2.65 percent to finish at 24,654.70, while the BSE Sensex index declined ...Read More >
Chennai, Sep 27 (SocialNews.XYZ) Marumalarchi Dravida Munnetra Kazhagam (MDMK) general secretary Vaiko has warned that the United States' latest decision to impose a steep 100 per cent import duty on medicines could deal a severe blow to India's pharmaceutical exports and trigger a wider trade crisis. Quoting data from the World Trade Organization (WTO), Vaiko said pharmaceuticals form India's single largest industrial export segment. Each year, India ships about $12.7 billion worth of medicin ...Read More >
HYDERABAD: Even as Donald Trump dashed off a missive announcing 100 per cent tariffs on branded, patented pharma products, Hyderabad, which has a significant number of pharma companies exporting to the US, may not see an impact, said industry officials. "The announcement is vague. The use of terms branded and patent in the message leaves scope for varied interpretation. India is predominantly a generic exporter and I don't think it impacts Hyderabad or even India," said R Udaya Bhasker, former ...Read More >
Ministry of External Affairs (MEA) Official Spokesperson Randhir Jaiswal, reacting to US President Donald Trump's imposition of 100% tariffs on imports of branded and patented pharmaceutical drugs from October 1, 2025, said the government is monitoring the situation closely. On Thursday, the Trump administration announced that starting October 1, 2025, it will be imposing a 100% tariff on any branded or patented pharmaceutical product, unless a company is building their pharmaceutical manufactu ...Read More >
Published on: September 26, 2025 5:46 PM The United States has announced a 100% tariff on Indian pharmaceutical imports, deepening trade tensions between the two countries. US President Donald Trump made the announcement on his social media platform, Truth Social. The new tariff will take effect from October 1. However, Trump said companies opening drug manufacturing plants in the US will be exempt. He cited national security as the main reason for the decision. India is among the world's larg ...Read More >
New Delhi, Sep 26 (PTI) US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 is unlikely to have an immediate impact on Indian exports, as it will affect only patented and branded products, not generic medicines, pharma industry players said on Friday. Indian Pharmaceutical Alliance (IPA), which represents 23 leading Indian pharmaceutical firms, including Dr Reddy's Laboratories, Sun Pharma, Lupin and Zydus Lifesciences, noted that Trump' ...Read More >
New Delhi: US President Donald Trump's decision to impose 100% tariffs on branded and patented drug exports has shaken Indian pharmaceutical markets, despite most of India's $10 billion US sales being in generics. The uncertainty lies in whether complex generics and specialty medicines will be included, a move that could directly impact leading players like Sun Pharma, Dr. Reddy's, Cipla, Zydus Lifesciences, and others. Stocks Facing Highest Exposure Dr. Reddy's emerges as the most vulnerable, ...Read More >
New Delhi [India], September 26 (ANI): European countries are expected to face the most immediate and severe impact from the new U.S. tariffs on imported branded or patented pharmaceutical products, while India may remain less affected for now, according to a press release by the Global Trade Research Initiative (GTRI). On Friday, U.S. President Donald Trump announced that from October 1, a 100 per cent tariff would be imposed on all imported branded or patented pharmaceutical products, unless ...Read More >
New Delhi [India], September 26 (ANI): India's pharmaceutical exports are not expected to face a major impact following the recent announcement of a 100 per cent tariff on branded and patented pharmaceutical products by the US, said Sudarshan Jain, General Secretary of the Indian Pharmaceutical Alliance (IPA). Speaking to ANI on Friday, Jain said that India's exports to the US primarily consist of generic drugs and active pharmaceutical ingredients (APIs), which are not covered under this tarif ...Read More >
New Delhi [India], September 26 (ANI):Indian Pharmaceutical Alliance has said that the US President Donald Trump's announcement of tariffs of up to 100 per cent on imports of branded and patented pharmaceuticals starting October 1 specifically refers to patented or branded products, and not impact generic medicines. Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said, "The executive order refers to patented / branded products supplied to the US. It is not applicable to ge ...Read More >
New Delhi, Sep 26 (PTI) Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines. Reacting to the development, IPA Secretary General Sudarshan Jain said in a statement, "It is not applicable to generics medicines." Trump's statement refers to patented and branded products supplied to US, he added. In his post on social me ...Read More >
Mumbai, September 26: The Indian benchmark indices opened lower on Friday, following US President Donald Trump's announcement of tariffs on pharma imports and sustained selling by foreign institutional investors. As of 9.25 am, Sensex was down 388 points, or 0.48 per cent at 80,771 and Nifty was down 119 points, or 0.48 per cent at 24,771. Shares of Indian and other Asian pharmaceutical companies fell after Trump announced tariffs of up to 100 per cent on imports of branded and patented pharmace ...Read More >
Mumbai, Sep 26 (SocialNews.XYZ) The Indian benchmark indices opened lower on Friday, following US President Donald Trump's announcement of tariffs on pharma imports and sustained selling by foreign institutional investors. As of 9.25 am, Sensex was down 388 points, or 0.48 per cent at 80,771 and Nifty was down 119 points, or 0.48 per cent at 24,771. Shares of Indian and other Asian pharmaceutical companies fell after Trump announced tariffs of up to 100 per cent on imports of branded and paten ...Read More >
New Delhi [India], September 26 (ANI): United States President Donald Trump announced on Friday that his administration will impose a 100 per cent tariff on branded and patented pharmaceutical products beginning October 1, 2025, unless the manufacturing companies establish production facilities in the United States. The Indian pharmaceutical sector supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicines in the UK. ...Read More >
MUMBAI (Reuters) -The Indian rupee is likely to stay under pressure on Friday and could slip to an all-time low after U.S. President Donald Trump unveiled a new round of tariffs, including a 100% duty on any branded or patented pharmaceutical products. The 1-month non-deliverable forward indicated the rupee will open around the all-time low of 88.7975 hit earlier this week, compared with Thursday's close of 88.6650. Meanwhile, on Thursday, Trump said duties on branded drugs, heavy-duty trucks ...Read More >
New Delhi, Sep 15 (SocialNews.XYZ) India's total exports of merchandise and services clocked a robust growth of 9.34 per cent in August to $69.16 billion compared to the same month of the previous year, according to official figures released by the Commerce and Industry Ministry on Monday. The country's merchandise exports during August 2025 went up to $35.10 billion as compared to $32.89 billion in August 2024 despite the economic uncertainties in the global market triggered by the US tariff h ...Read More >
Eight crop segments -- rice, cotton, wheat, soybean, chillies, grapes, sugarcane and gram -- contribute about 65 per cent of the domestic agrochemical market. India's agrochemical exports nearly trebled in 10 years to $3.3 billion in FY25, up from $1.3 billion in 2014-15, making the country the third-largest exporter of agrochemicals after China and the US, a report by the Agro-Chemicals Federation of India (ACFI) and Deloitte released late last evening showed. To sustain the momentum, ACFI ha ...Read More >
HÀ NỘI While more than half of people living with rare diseases in Việt Nam are children, access to rare disease treatment remains limited due to high costs and a lack of comprehensive health insurance coverage. According to the Ministry of Health, Việt Nam has about six million people living with rare diseases, 58 per cent of whom are children. Data shows that an alarming 30 per cent of children with rare diseases die before the age of five. Rare diseases often include metabolic disord ...Read More >
New Delhi [India], July 14 (ANI): Opening India's dairy sector to US imports could result in an annual loss of Rs 1.03 lakh crore to Indian dairy farmers, according to a recent report by the State Bank of India (SBI). The report cautioned that the move would significantly impact the livelihoods of small dairy farmers, as the US dairy sector is heavily subsidized. Also Read | Bitcoin Price Hits All-Time High Today, Cryptocurrency Surpasses USD 1,21,000 Mark for First Time. SBI stated, "If the ...Read More >
NEW DELHI: In his latest salvo against US trading partners, US President Donald Trump threatened aggressive tariffs on drug imports, raising fresh concerns for the export-intensive domestic pharma sector. "Pharma is going to be tariffed at a very, very high rate, like 200%," Trump said late on July 8. Tariffs on pharmaceuticals would come into effect after a grace period of at least a year, he added. Domestic pharma stocks, including Sun Pharma, Aurobindo, and Lupin, were fairly resilient, closi ...Read More >
Jamnagar: In a major boost to affordable healthcare in Gujarat, Jamnagar MP Poonamben Maadam inaugurated the Pradhan Mantri Jan Aushadhi Kendra on Wednesday at Guru Gobind Government Hospital. The event saw the presence of the city's Mayor, BJP leaders, and the District Chief, marking a significant milestone in the region's healthcare infrastructure. The Jan Aushadhi Kendra, part of the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), aims to make quality medicines accessible to all, pa ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.